EcoDrugPlus

Ribosomal Protein L13

Ensembl ID : ENSCAFG00020005125
Gene Symbol: RPL13
3 Cross references
238 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSCAFG00020024742
Gene Symbol: RPL15
3 Cross references
204 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSCAFG00020026370
Gene Symbol: RPL18
2 Cross references
226 Possible Orthologues:

Ribosomal Protein L18-Like

Ensembl ID : ENSCAFG00020003675
Gene Symbol: LOC112653245
2 Cross references
246 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSCAFG00020011844
Gene Symbol: RPL18A
2 Cross references
247 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSCAFG00020022962
Gene Symbol: RPL19
3 Cross references
308 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSCAFG00020008674
Gene Symbol: RPL22
3 Cross references
233 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSCAFG00020023011
Gene Symbol: RPL23
2 Cross references
166 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSCAFG00020008829
Gene Symbol: RPL24
3 Cross references
242 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSCAFG00020012981
Gene Symbol: RPL27
3 Cross references
188 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSCAFG00020015496
Gene Symbol: RPL28
2 Cross references
216 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSCAFG00020022376
Gene Symbol: RPL29
2 Cross references
308 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).